2/253/1667448621 |
您所在的位置：网站首页 › 2/253/1667448621 |
data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/23417882Cardiovascular risk factors among long-term survivors of …网页Purpose: Individuals diagnosed with high survival cancers will often die of cardiovascular disease (CVD) rather than a recurrence of their cancer, yet CVD risk factors may be overlooked during survivorship care. We assess the prevalence of CVD risk factors among long-term cancer survivors and compare results to survey data from the general …
发布时间：2024-07-10data-id="" iid="">120.253.60.248http://120.253.60.248:11001宁夏红墩子煤业网络智能办公系统网页二维码失效，请点击图片刷新
发布时间：2024-07-10data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/23513742TLC-bioautographic evaluation of in vitro anti-tyrosinase and …网页2013 Feb;8(2):253-6. Authors Biswapriya B Misra 1 , Satyahari Dey. Affiliation 1 Plant Biotechnology Laboratory, Department of Biotechnology, Indian Institute of Technology Kharagpur, Midnapore (West), Kharagpur-721302, West Bengal, India. [email protected]; PMID: 23513742 ...
发布时间：2024-07-10data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/32128464Antibacterial and angiogenic chitosan microneedle array …网页2020年2月25日 · Abstract. A patch with the capability of avoiding wound infection and promoting tissue remolding is of great value for wound healing. In this paper, we develop a biomass chitosan microneedle array (CSMNA) patch integrated with smart responsive drug delivery for promoting wound healing. Chitosan possesses many outstanding features …
发布时间：2024-07-10data-id="" iid="">182.92.200.144http://182.92.200.144/CN/abstract/abstract860.shtml有氧糖酵解治疗靶点及其靶向药物的研究进展网页2021年12月16日 · 但是， 有氧糖酵解靶向治疗目前也存在两个困境：①肿瘤细胞本身的代谢异质性；②免疫系统在靶向糖酵解治疗过程中也会受到损伤。. 本文就有氧糖酵解的各个靶点及其靶向药物在肿瘤治疗中的研究进展及其靶向治疗目前存在的困境展开综述。. Abstract：Aerobic ...
发布时间：2024-07-10